It is especially beneficial for those with a BMI of 30 or higher, or a BMI of 27 or higher with obesity-related health conditions such as hypertension, type 2 diabetes, or dyslipidemia
Wegovy pill approved in the US as first oral GLP-1 for chronic weight management
Weight Management and Obesity GLP-1 agonists have revolutionized obesity treatment, offering the first medications producing weight loss comparable to bariatric surgery
GLP-1 receptor agonists mimic incretin hormones, suppressing appetite, slowing gastric emptying, and improving insulin sensitivity
Buyer profile: Licensed healthcare professionals, hospital pharmacies, compounding facilities, infusion centres, EMS teams, medspas and aesthetic practices, dental and veterinary practices, and institutional procurement teams
It encompasses a holistic approach, rendering it more than just a solution for weight